The Treatment Of Neuroblastoma With Vitamin B12
British Empire Cancer Campaign 35(2): 1957; 227-230
View Original Source →Case Details
Personal Characteristics
Fifteen patients
Clinical Characteristics
Tumour regression, intercurrent infection (poliomyelitis)
Remission Characteristics
Fifteen patients had shown evidence of tumour regression, and ten were alive in remission at intervals from 7 months to 6 years from the commencement of treatment. One further child had succumbed to an intercurrent infection (poliomyelitis) and was then found to be free from tumour at autopsy. Regression in the remaining four children was of a temporary nature.
Treatment & Mechanisms
Clinical Treatment
Massive vitamin b12 therapy
Additional Notes
An annual survey of an investigation into the response of neuroblastoma to massive Vitamin B12 therapy has been provided in the Annual Reports from 1953 to 1956 inclusive. In the last issue the entire series was reviewed covering twenty-eight children where treatment was commenced between January 1951 and June 1956. Up to June 1957 treatment has been extended to include a further eight patients with neuroblastoma. Case summaries of Cases 31-38 are included.